Novogene Co Ltd Class A 688315
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 14.39
- Day Range
- CNY 13.64–14.39
- 52-Week Range
- CNY 12.17–33.56
- Bid/Ask
- CNY 13.71 / CNY 13.72
- Market Cap
- CNY 5.71 Bil
- Volume/Avg
- 3.3 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 43.73
- Price/Sales
- 2.90
- Dividend Yield (Trailing)
- 0.33%
- Dividend Yield (Forward)
- 0.33%
- Total Yield
- 0.33%
Company Profile
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,144
- Website
- https://en.novogene.com
Comparables
Valuation
Metric
|
688315
|
000710
|
688253
|
---|---|---|---|
Price/Earnings (Normalized) | 43.73 | — | 23.42 |
Price/Book Value | 2.46 | 1.70 | 2.80 |
Price/Sales | 2.90 | 2.90 | 8.92 |
Price/Cash Flow | 23.42 | 30.36 | 13.52 |
Price/Earnings
688315
000710
688253
Financial Strength
Metric
|
688315
|
000710
|
688253
|
---|---|---|---|
Quick Ratio | 1.86 | 1.63 | 10.60 |
Current Ratio | 2.40 | 2.02 | 11.04 |
Interest Coverage | 109.58 | — | 1,693.02 |
Quick Ratio
688315
000710
688253
Profitability
Metric
|
688315
|
000710
|
688253
|
---|---|---|---|
Return on Assets (Normalized) | 5.06% | −13.01% | 4.47% |
Return on Equity (Normalized) | 7.69% | −18.59% | 4.81% |
Return on Invested Capital (Normalized) | 7.55% | −15.87% | 4.51% |
Return on Assets
688315
000710
688253
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vgqfmdsjkg | Vjm | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Vmtbtjk | Sscbrz | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Thhqzgsr | Znjlr | $108.2 Bil | |
MRNA
| Moderna Inc | Tnmnkvh | Pmwb | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Rqztlhngt | Xmfdh | $21.8 Bil | |
ARGX
| argenx SE ADR | Gdggzbjg | Sxhds | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Kjwjrqd | Mgjhdhl | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Qmcrblfr | Txscys | $14.6 Bil | |
INCY
| Incyte Corp | Zbfzcgwk | Brsxmq | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Prcdlnsng | Bxqjjtw | $12.3 Bil |